Summary & Overview
HCPCS G9518: Documentation of Active Injection Drug Use
HCPCS Level II code G9518 denotes documentation that a patient has active injection drug use. Nationally, standardized documentation of injection drug use status supports coordinated care, risk mitigation (including infection risk and overdose risk), and population-level monitoring of substance use trends. The code provides a discrete way to record active injection drug use in the medical record and on claims, which can inform care pathways and service planning.
Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical meaning and typical contexts where it is used, plus guidance on the kinds of benchmarks and policy topics that commonly accompany codes for substance use documentation. Content covers where the code applies clinically, typical sites of service, and the role of the code in care workflows. Information on modifiers, taxonomies, ICD-10 mappings, related codes, and payer-specific coverage practices is noted as available where data exists; when not provided in the input, that data is identified as not available.
This summary is written for a national audience and focuses on the code’s clinical and administrative purpose rather than state-specific rules or reimbursement advice.
Billing Code Overview
HCPCS Level II code G9518 documents active injection drug use. This code captures clinician documentation that a patient is currently using injection drugs, which is a clinical status relevant to risk assessment, care planning, and certain clinical interventions.
Service Type: Behavioral health / substance use assessment
Typical Site of Service: Outpatient clinic, emergency department, inpatient setting, or any clinical encounter where substance use status is assessed
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 28-year-old individual presenting to an emergency department, community health clinic, addiction medicine program, or hospital-based intensive outpatient service with complications or concerns related to ongoing injection drug use (IDU). The encounter may be initiated for wound infection, bacteremia, endocarditis workup, overdose follow-up, or linkage-to-care services. Clinical workflow includes intake screening that documents active injection behaviors, a focused history and physical, assessment of injection sites, wound and vascular access inspection, relevant laboratory testing (blood cultures, CBC, metabolic panel), and documentation of substance use status in the medical record. Behavioral health and social work consults are frequently involved to assess readiness for treatment, harm reduction counseling, and referral to syringe services, opioidagonist therapy, or infectious disease follow-up. The documentation of active injection drug use serves as a clinical data element for care planning, infection control precautions, care coordination, and case management activities, and is often captured as a discrete entry in the encounter note or problem list to support billing and quality reporting.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | When documentation supports substantially greater work or complexity related to care coordination for complications of active injection drug use |
23 | Unusual anesthesia | When an unusual anesthesia circumstance is required for a procedure related to managing IDU complications |
52 | Reduced services | When the intended service is partially reduced or not completed due to patient condition or refusal |
53 | Discontinued procedure | When a procedure is started but halted due to emergent deterioration related to injection-related complications |
54 | Surgical care only | When only the surgical portion of care is billed and postoperative care is billed separately |
55 | Postoperative management only | When only postoperative care is billed, such as ongoing wound care after incision and drainage |
56 | Preoperative management only | When only preoperative evaluation is billed prior to definitive management of injection-related infection |
62 | Two surgeons | When two surgeons with different specialties jointly perform a complex debridement or vascular procedure related to IDU complications |
AS | Physician assistant, nurse practitioner, or clinical nurse specialist services for assistant at surgery | When an advanced practice clinician assists during operative management of injection-associated injuries |
QK | Medical direction of two, three, or four assistants | When the surgeon directs multiple assistants during complex operative repair after injection-related trauma |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 207Q00000X | Addiction Medicine | Manages active injection drug use, medication-assisted treatment, and harm reduction interventions |
| 208D00000X | Emergency Medicine | Frequent site of documentation for acute complications and initial IDU identification |
| 207L00000X | Infectious Disease | Consults for bacteremia, endocarditis, skin and soft tissue infections associated with injection |
| 207P00000X | Internal Medicine | Hospitalists and primary care clinicians documenting IDU status for inpatient and outpatient continuity |
| 363LF0000X | Pain Medicine | May be involved when injection-related complications overlap with pain management needs |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
F11.20 | Opioid dependence, uncomplicated | Common diagnosis associated with active injection opioid use; supports linkage to medication-assisted treatment |
F19.20 | Other psychoactive substance dependence, uncomplicated | Captures dependence on non-opioid substances commonly injected (stimulants, polysubstance use) |
I33.0 | Acute and subacute infective endocarditis | Serious complication of injection drug use prompting documentation of active IDU for diagnostic and treatment planning |
A41.9 | Sepsis, unspecified organism | May result from bacteremia related to injection practices; documentation of active IDU is clinically relevant for source control |
L03.116 | Cellulitis of right lower limb | Example of soft tissue infection at injection sites; laterality varies by presentation |
L02.419 | Cutaneous abscess of unspecified toe | Represents localized abscesses commonly found at injection sites |
T80.2XXA | Infection following infusion, transfusion and therapeutic injection, initial encounter | Relevant when an iatrogenic or therapeutic injection becomes infected; documentation of active injection use informs differential |
Z72.0 | Tobacco use, unspecified | Frequently co-occurring behavioral health risk; included for comprehensive social history documentation |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
10060 | Incision and drainage of abscess; simple or single | Often performed for skin and soft tissue infections at injection sites discovered after documentation of active IDU |
10061 | Incision and drainage of abscess; complicated or multiple | Used when multiple or complex abscesses related to injection drug use require drainage |
36415 | Collection of venous blood by venipuncture | Routine diagnostic step to obtain labs, including blood cultures and CBC, after identification of active injection drug use |
87070 | Culture, bacterial; any other source except urine, blood or stool; aerobic, with isolation and presumptive identification of isolates | Applied when wound cultures from injection sites are submitted |
87040 | Culture, aerobic, bacterial; blood culture, aerobic | Used for blood cultures when bacteremia is suspected in patients with active IDU |
99406 | Smoking and tobacco use cessation counseling visit, intermediate, greater than 3 minutes up to 10 minutes | Example of a brief counseling code; behavioral counseling codes such as these are analogous to substance use counseling sessions documented after IDU identification |